Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1

Comprehensive molecular testing plays a critical role in the choice of treatment for non-small lung cell cancer (NSCLC). The analysis of druggable alterations in EGFR, BRAF, MET, KRAS, ALK, ROS1, RET and NTRK1/2/3 genes is more or less standardized and can be achieved using a single diagnostic platf...

Descripción completa

Detalles Bibliográficos
Autores principales: Imyanitov, Evgeny N., Ivantsov, Alexandr O., Tsimafeyeu, Ilya V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554524/
https://www.ncbi.nlm.nih.gov/pubmed/33102215
http://dx.doi.org/10.3389/fonc.2020.549198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554524/
https://www.ncbi.nlm.nih.gov/pubmed/33102215
http://dx.doi.org/10.3389/fonc.2020.549198

Ejemplares similares